Cooper Current Ratio 2012-2026 | COO
Current and historical current ratio for Cooper (COO) from 2012 to 2026. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Cooper current ratio for the three months ending April 30, 2026 was 0.00.
| Cooper Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2026-04-30 | $2.30B | $1.81B | 1.27 |
| 2026-01-31 | $2.13B | $1.60B | 1.34 |
| 2025-10-31 | $2.11B | $1.11B | 1.89 |
| 2025-07-31 | $2.14B | $1.01B | 2.12 |
| 2025-04-30 | $2.13B | $1.01B | 2.10 |
| 2025-01-31 | $1.99B | $1.00B | 1.99 |
| 2024-10-31 | $1.95B | $1.02B | 1.91 |
| 2024-07-31 | $1.93B | $0.97B | 1.99 |
| 2024-04-30 | $1.86B | $0.95B | 1.95 |
| 2024-01-31 | $1.79B | $0.97B | 1.86 |
| 2023-10-31 | $1.71B | $0.97B | 1.76 |
| 2023-07-31 | $1.71B | $0.99B | 1.72 |
| 2023-04-30 | $1.60B | $0.95B | 1.69 |
| 2023-01-31 | $1.58B | $0.92B | 1.72 |
| 2022-10-31 | $1.53B | $1.28B | 1.20 |
| 2022-07-31 | $1.60B | $1.38B | 1.16 |
| 2022-04-30 | $1.74B | $1.65B | 1.05 |
| 2022-01-31 | $1.70B | $1.66B | 1.02 |
| 2021-10-31 | $1.47B | $0.73B | 2.00 |
| 2021-07-31 | $1.48B | $1.06B | 1.39 |
| 2021-04-30 | $1.32B | $0.99B | 1.33 |
| 2021-01-31 | $1.30B | $0.96B | 1.35 |
| 2020-10-31 | $1.27B | $1.00B | 1.27 |
| 2020-07-31 | $1.32B | $1.13B | 1.17 |
| 2020-04-30 | $1.17B | $1.03B | 1.14 |
| 2020-01-31 | $1.15B | $1.07B | 1.08 |
| 2019-10-31 | $1.16B | $1.11B | 1.05 |
| 2019-07-31 | $1.15B | $0.89B | 1.29 |
| 2019-04-30 | $1.14B | $0.94B | 1.21 |
| 2019-01-31 | $1.19B | $0.94B | 1.27 |
| 2018-10-31 | $1.09B | $0.54B | 2.03 |
| 2018-07-31 | $1.19B | $0.46B | 2.58 |
| 2018-04-30 | $1.27B | $0.46B | 2.76 |
| 2018-01-31 | $1.18B | $0.42B | 2.83 |
| 2017-10-31 | $0.95B | $0.40B | 2.41 |
| 2017-07-31 | $0.93B | $0.37B | 2.51 |
| 2017-04-30 | $0.96B | $0.34B | 2.79 |
| 2017-01-31 | $0.88B | $0.52B | 1.71 |
| 2016-10-31 | $0.94B | $0.54B | 1.73 |
| 2016-07-31 | $0.93B | $0.32B | 2.90 |
| 2016-04-30 | $0.92B | $0.32B | 2.84 |
| 2016-01-31 | $0.85B | $0.35B | 2.43 |
| 2015-10-31 | $0.84B | $0.57B | 1.48 |
| 2015-07-31 | $0.82B | $0.53B | 1.54 |
| 2015-04-30 | $0.80B | $0.54B | 1.49 |
| 2015-01-31 | $0.79B | $0.38B | 2.06 |
| 2014-10-31 | $0.79B | $0.44B | 1.79 |
| 2014-07-31 | $0.90B | $0.30B | 3.01 |
| 2014-04-30 | $0.77B | $0.27B | 2.89 |
| 2014-01-31 | $0.70B | $0.27B | 2.61 |
| 2013-10-31 | $0.75B | $0.32B | 2.33 |
| 2013-07-31 | $0.71B | $0.25B | 2.83 |
| 2013-04-30 | $0.68B | $0.23B | 2.95 |
| 2013-01-31 | $0.68B | $0.23B | 3.01 |
| 2012-10-31 | $0.66B | $0.26B | 2.51 |
| 2012-07-31 | $0.63B | $0.23B | 2.71 |
| 2012-04-30 | $0.58B | $0.23B | 2.53 |
| 2012-01-31 | $0.56B | $0.21B | 2.69 |
| 2011-10-31 | $0.54B | $0.27B | 2.02 |
| 2011-07-31 | $0.54B | $0.24B | 2.29 |
| 2011-04-30 | $0.54B | $0.21B | 2.61 |
| 2011-01-31 | $0.50B | $0.19B | 2.71 |
| 2010-10-31 | $0.49B | $0.20B | 2.46 |
| 2010-07-31 | $0.49B | $0.22B | 2.19 |
| 2010-04-30 | $0.49B | $0.21B | 2.37 |
| 2010-01-31 | $0.50B | $0.18B | 2.78 |
| 2009-10-31 | $0.50B | $0.18B | 2.87 |
| 2009-07-31 | $0.52B | $0.21B | 2.44 |
| 2009-04-30 | $0.53B | $0.21B | 2.47 |
| 2009-01-31 | $0.54B | $0.25B | 2.11 |
| 2008-10-31 | $0.53B | $0.26B | 2.06 |
| 2008-07-31 | $0.57B | $0.24B | 2.37 |
| 2008-04-30 | $0.56B | $0.24B | 2.31 |
| 2008-01-31 | $0.53B | $0.24B | 2.19 |
| 2007-10-31 | $0.52B | $0.29B | 1.81 |
| 2007-07-31 | $0.51B | $0.28B | 1.80 |
| 2007-04-30 | $0.50B | $0.26B | 1.94 |
| 2007-01-31 | $0.49B | $0.23B | 2.15 |
| 2006-10-31 | $0.46B | $0.28B | 1.65 |
| 2006-07-31 | $0.46B | $0.25B | 1.80 |
| 2006-04-30 | $0.44B | $0.24B | 1.81 |
| 2006-01-31 | $0.45B | $0.23B | 2.00 |
| 2005-10-31 | $0.44B | $0.26B | 1.72 |
| 2005-07-31 | $0.44B | $0.22B | 2.02 |
| 2005-04-30 | $0.43B | $0.22B | 1.97 |
| 2005-01-31 | $0.44B | $0.20B | 2.17 |
| 2004-10-31 | $0.30B | $0.11B | 2.73 |
| 2004-07-31 | $0.27B | $0.11B | 2.34 |
| 2004-04-30 | $0.25B | $0.11B | 2.24 |
| 2004-01-31 | $0.28B | $0.11B | 2.59 |
| 2003-10-31 | $0.26B | $0.12B | 2.29 |
| 2003-07-31 | $0.24B | $0.11B | 2.15 |
| 2003-04-30 | $0.21B | $0.10B | 2.03 |
| 2003-01-31 | $0.21B | $0.10B | 2.09 |
| 2002-10-31 | $0.20B | $0.13B | 1.57 |
| 2002-07-31 | $0.20B | $0.12B | 1.68 |
| 2002-04-30 | $0.20B | $0.18B | 1.10 |
| 2002-01-31 | $0.15B | $0.09B | 1.70 |
| 2001-10-31 | $0.16B | $0.07B | 2.28 |
| 2001-07-31 | $0.13B | $0.07B | 2.00 |
| 2001-04-30 | $0.13B | $0.05B | 2.35 |
| 2001-01-31 | $0.12B | $0.06B | 1.90 |
| 2000-10-31 | $0.11B | $0.07B | 1.73 |
| 2000-07-31 | $0.11B | $0.05B | 2.27 |
| 2000-04-30 | $0.10B | $0.05B | 2.08 |
| 2000-01-31 | $0.09B | $0.05B | 2.08 |
| 1999-10-31 | $0.10B | $0.04B | 2.40 |
| 1999-07-31 | $0.10B | $0.05B | 2.07 |
| 1999-04-30 | $0.09B | $0.05B | 1.90 |
| 1999-01-31 | $0.11B | $0.04B | 2.62 |
| 1998-10-31 | $0.12B | $0.05B | 2.49 |
| 1998-07-31 | $0.10B | $0.04B | 2.25 |
| 1998-04-30 | $0.08B | $0.05B | 1.83 |
| 1998-01-31 | $0.08B | $0.04B | 1.92 |
| 1997-10-31 | $0.07B | $0.03B | 2.04 |
| 1997-07-31 | $0.09B | $0.07B | 1.35 |
| 1997-04-30 | $0.05B | $0.04B | 1.11 |
| 1997-01-31 | $0.04B | $0.04B | 0.98 |
| 1996-10-31 | $0.04B | $0.03B | 1.28 |
| 1996-07-31 | $0.04B | $0.03B | 1.11 |
| 1996-04-30 | $0.04B | $0.03B | 1.06 |
| 1996-01-31 | $0.04B | $0.03B | 1.07 |
| 1995-10-31 | $0.04B | $0.04B | 1.04 |
| 1995-07-31 | $0.04B | $0.04B | 1.05 |
| 1995-04-30 | $0.04B | $0.04B | 1.02 |
| 1995-01-31 | $0.04B | $0.04B | 0.99 |
| 1994-10-31 | $0.04B | $0.04B | 1.03 |
| 1994-07-31 | $0.05B | $0.05B | 0.97 |
| 1994-04-30 | $0.04B | $0.05B | 0.87 |
| 1994-01-31 | $0.05B | $0.05B | 0.94 |
| 1993-10-31 | $0.05B | $0.04B | 1.38 |
| 1993-07-31 | $0.07B | $0.08B | 0.86 |
| 1993-04-30 | $0.09B | $0.05B | 1.61 |
| 1993-01-31 | $0.10B | $0.04B | 2.50 |
| 1992-10-31 | $0.12B | $0.05B | 2.23 |
| 1992-07-31 | $0.14B | $0.05B | 2.79 |
| 1992-04-30 | $0.15B | $0.04B | 4.06 |
| 1992-01-31 | $0.18B | $0.06B | 3.22 |
| 1991-10-31 | $0.17B | $0.05B | 3.37 |
| 1991-07-31 | $0.17B | $0.04B | 3.90 |
| 1991-04-30 | $0.18B | $0.05B | 3.42 |
| 1991-01-31 | $0.19B | $0.04B | 4.36 |
| 1990-10-31 | $0.20B | $0.05B | 4.36 |
| 1990-07-31 | $0.20B | $0.05B | 4.29 |
| 1990-04-30 | $0.20B | $0.05B | 4.36 |
| 1990-01-31 | $0.23B | $0.06B | 3.73 |
| 1989-10-31 | $0.28B | $0.06B | 4.30 |
| 1989-07-31 | $0.30B | $0.08B | 3.59 |
| 1989-04-30 | $0.51B | $0.41B | 1.25 |
| 1989-01-31 | $0.73B | $0.55B | 1.32 |
| 1988-10-31 | $0.65B | $0.36B | 1.80 |
| 1988-07-31 | $0.63B | $0.62B | 1.02 |
| 1988-04-30 | $0.62B | $0.57B | 1.08 |
| 1988-01-31 | $0.65B | $0.58B | 1.12 |
| 1987-10-31 | $0.40B | $0.55B | 0.73 |
| 1987-04-30 | $0.64B | $0.56B | 1.13 |
| 1987-01-31 | $0.47B | $0.38B | 1.24 |
| 1986-10-31 | $0.35B | $0.25B | 1.38 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.894B | $4.092B |
| The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |